Literature DB >> 3004686

AIDS and taurolin.

P Bayardelle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3004686      PMCID： PMC1490793     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  The anti-endotoxin activity of Taurolin in experimental animals.

Authors:  R W Pfirrmann; G B Leslie
Journal:  J Appl Bacteriol       Date:  1979-02

2.  Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome.

Authors:  W Rozenbaum; D Dormont; B Spire; E Vilmer; M Gentilini; C Griscelli; L Montagnier; F Barre-Sinoussi; J C Chermann
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

3.  Taurolin, a new chemotherapeutic agent.

Authors:  M K Browne; G B Leslie; R W Pfirrmann
Journal:  J Appl Bacteriol       Date:  1976-12

4.  Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III.

Authors:  H Mitsuya; M Popovic; R Yarchoan; S Matsushita; R C Gallo; S Broder
Journal:  Science       Date:  1984-10-12       Impact factor: 47.728

5.  Inactivation of lymphadenopathy associated virus by chemical disinfectants.

Authors:  B Spire; F Barré-Sinoussi; L Montagnier; J C Chermann
Journal:  Lancet       Date:  1984-10-20       Impact factor: 79.321

6.  The relationship between structure and activity of taurolin.

Authors:  E Myers; M C Allwood; M J Gidley; J K Sanders
Journal:  J Appl Bacteriol       Date:  1980-02

7.  The treatment of peritonitis by an antiseptic - taurolin.

Authors:  M K Browne
Journal:  Pharmatherapeutica       Date:  1981

8.  Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes.

Authors:  J B McCormick; J P Getchell; S W Mitchell; D R Hicks
Journal:  Lancet       Date:  1984-12-15       Impact factor: 79.321
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.